Invesco Dynamic Biotechnology & Genome ETF

  • PBE


, ,

Rank

Rank Universe
15 23

Summary

The fund seeks to replicate the total return performance of the benchmark index, before fees and expenses, by investing in companies in the United States.

The investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.

Next, the research team invests significantly in the securities that compris More

Webiste

Price

  • $ 56.58 ( -5.03 )
  • Apr 10, 2025
    Last Close
  • Net Assets
  • 52-Week High/Low
  • $72.2 - $56

  • Expense Ratio
  • -

Performance

YTD

0%

3 Year

-10.77%

5 Year

15.62%

Best

62.22%

2013

Worst

-61.21%

2005

Documents

NAV

Annual Return

Alpha - PBE and S&P